Tumblelog by Soup.io
Newer posts are loading.
You are at the newest post.
Click here to check if anything new just came in.
rafeykeith

Gout's Silver Lining: A Lower Risk For Alzheimer's? ? Webmd

Gout may lessen Alzheimer risk: study - Yahoo News

"One paper doesn't make science." His team published their findings online March 4 in the Annals of the Rheumatic Diseases. According to the U.S. Centers for Disease Control and Prevention, gout is the most common form of inflammatory arthritis , affecting more than 8 million Americans. It is caused by a buildup of uric acid crystals in tissues that can trigger painful flare-ups in the joints, especially the legs and feet. In the new study, Choi's group looked at a database involving the medical records of 3.7 million British patients over the age of 40, tracked between 1995 and 2013. The investigators looked specifically at two groups: more than 59,000 gout patients and nearly 239,000 gout-free patients. According to the researchers, more than 1,900 of the gout-free patients developed Alzheimer's disease , compared to only about 300 gout patients.
For the original version including any supplementary images or video, visit http://www.webmd.com/alzheimers/news/20150305/gouts-silver-lining-a-lower-risk-for-alzheimers?src=RSS_PUBLIC

Gout may lessen Alzheimer risk - Yahoo News

It's so spicy that I wouldn't be surprised if there were some rye mixed in with the barley. Hell, my new favorite beer comes from Krebs, Okla., so I guess I wouldn't be surprised by anything anymore. This is Drunkspin Daily , the Concourse's adequate source for booze news, reviews, and bullshit. We'll be highlighting a beer a day in this space; please leave suggestions below. Will Gordon loves life and tolerates dissent. He lives in Cambridge, Mass., and some of his closest friends have met Certified Cicerones.
For the original version including any supplementary images or video, visit http://theconcourse.deadspin.com/the-best-beer-is-from-oklahoma-naturally-1689626687

View photo The same uric acid that can crystallise to cause gout, a form of arthritis, mayprotect against Alzheimer's, researchers say (AFP Photo/Emmanuel Dunand) Paris (AFP) - People who suffer from gout can take comfort in one thing: they may be less likely to develop Alzheimer's disease, researchers said Wednesday. The same uric acid that can crystallise to cause gout, a form of arthritis, may protect against Alzheimer's, they wrote in the online journal Annals of the Rheumatic Diseases. Testing a theory that antioxidant properties in uric acid may protect the brain, experts from the United States and Canada looked at the records of 3.7 million people over the age of 40 in a British database of medical charts. Researchers compared data on people with gout, and those without, who developed Alzheimer's disease in a followup period of about five years. The researchers identified 309 new cases of Alzheimer's among 59,224 gout sufferers with an average age of 65, and 1,942 cases among 238,805 non-sufferers. This amounted to a 24 percent lower risk of Alzheimer's disease for people with a history of gout, after factoring in differences in age, gender, bodyweight, lifestyle and health. "Our findings provide the first population-based evidence for the potential protective effect of gout on the risk of AD (Alzheimer's disease) and support the purported neuroprotective role of uric acid," the authors said in a statement. Gout happens when excess uric acid builds up in the blood, causing crystals to form around the joints, inflicting extreme pain and swelling.
For the original version including any supplementary images or video, visit http://news.yahoo.com/gout-may-lessen-alzheimer-risk-003621091.html

Revive Therapeutics Enters Into Advisory Agreement with Spinnaker Capital Markets Inc. - Yahoo Finance

The researchers identified 309 new cases of Alzheimer's among 59,224 gout sufferers with an average age of 65, and 1,942 cases among 238,805 non-sufferers. This amounted to a 24 percent lower risk of Alzheimer's disease for people with a history of gout, after factoring in differences in age, gender, bodyweight, lifestyle and health. "Our findings provide the first population-based evidence for the potential protective effect of gout on the risk of AD (Alzheimer's disease) and support the purported neuroprotective role of uric acid," the authors said in a statement.
For the original version including any supplementary images or video, visit http://news.yahoo.com/gout-may-lessen-alzheimer-risk-study-152116492.html

RUSSELL HIVELY: Food studies - News - Neosho Daily News - Neosho, MO - Neosho, MO

Doesnt drinking cherry juice cure gout? There have been studies of how good or bad eggs are. How can the food designed to nourish a pre-hatched chick be bad? How can milk be bad when it was created to nurture a young animal? Broccoli, raw carrots, asparagus, and celery are supposed to be good for us. If so, why arent these vegetables ground and put in baby bottles? Take a walk, dont take as advil for gout a fact all food studies, watch for pedestrians, use your signal lights, and see what you notice or think about while passing along Wildcat Boulevard.
For the original version including any supplementary images or video, visit http://www.neoshodailynews.com/article/20150306/NEWS/150309308/-1/news

The Best Beer Is From Oklahoma (Naturally)

The research professionals at Vince & Associates are proud to be recognized in the industry as a Center of Research Excellence. Vince & Associates currently operates a state-of-the-art, multimillion-dollar, 100-bed clinical pharmacology unit that combines the ultimate in subject safety and luxury. This early development unit has the upscale atmosphere necessary for the recruitment and retention of study volunteers in both short- and long-term clinical trials. From the safety and security of the controlled access unit to the added features of a movie theater and game rooms, no detail has been overlooked. About Altasciences Altasciences is the parent company of wholly owned subsidiaries Vince & Associates Clinical Research (Kansas, USA) twitter and Algorithme Pharma (Quebec, Canada). Both organizations provide comprehensive early stage clinical services in Phase I/IIa, including the necessary support services in this critical stage of drug development.
For the original version including any supplementary images or video, visit http://finance.yahoo.com/news/vince-associates-clinical-research-completes-140000389.html

Vince & Associates Clinical Research Completes CymaBay Therapeutics? Clinical Trial of Arhalofenate in Combination with Febuxostat - Yahoo Finance

(TSX VENTURE:RVV) is a clinical-stage company focused on commercializing treatments for gout and orphan drug indications such as Cystinuria, Wilson disease and Rett syndrome. Additional information on Revive is available at www.revivethera.com . CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS This news release includes certain information and statements about management's view of future events, expectations, plans and prospects that constitute "forward looking statements", which are not comprised of historical facts. Forward-looking statements may be identified by such terms as "believes", "anticipates", "intends", "expects", "estimates", "may", "could", "would", "will", or "plan", and similar expressions. Specifically, forward looking statements in this news release include, without limitation, statements regarding: the closing of the Offering and the use of proceeds therefrom; the Company's drug research and development plans; the timing of operations; and estimates of market conditions. These statements involve known and unknown risks, uncertainties, and other factors that may cause actual results or events, performance, or achievements of Revive to differ materially from those anticipated or implied in such forward-looking statements. The Company believes that the expectations reflected in these forward-looking statements are reasonable, but there can be no assurance that actual results will meet management's expectations.
For the original version including any supplementary images or video, visit http://finance.yahoo.com/news/revive-therapeutics-enters-advisory-agreement-170000264.html

Don't be the product, buy the product!

Schweinderl